Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

Clinical trial NCT00368056 · COMPLETED

Trial details

NCT number: NCT00368056
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2005-04-01
Primary completion: 2006-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.